Abstract
Definitive answers regarding arsenic health risks at low exposures will be elusive without additional research.The adequacy of the current maximum contaminant level (MCL) for arsenic is being evaluated by the US Environmental Protection Agency. If recent theoretical estimates of chronic effects and cancer risks prove accurate, the current MCL may not effectively protect health. Knowledge of arsenic pharmacokinetics and mechanisms in humans, however, is not complete enough to provide a definitive answer, and current epidemiologic evidence is too inconsistent and too fraught with uncertainty regarding arsenic exposure to be helpful in assessing low‐level risks.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
